This is a preview of subscription content, log in via an institution to check access.
References
Gershenwald JE, Thompson W, Mansfield PF, et al. Multi-institutional melanoma lymphatic mapping experience: the prognostic value of sentinel lymph node status in 612 stage I or II melanoma patients. J Clin Oncol. 1999;17(3):976–983.
Faries MB, Thompson JF, Cochran AJ, et al. Completion dissection or observation for sentinel-node metastasis in melanoma. N Engl J Med. 2017;376(23):2211–2222.
van Akkooi AC, Nowecki ZI, Voit C, et al. Sentinel node tumor burden according to the Rotterdam criteria is the most important prognostic factor for survival in melanoma patients: a multicenter study in 388 patients with positive sentinel nodes. Ann. Surg. 2008;248(6):949-955.
Koonce S, Newman M. A systematic review of concordance between indocyanine green and 99m technetium sentinel lymph node identification in melanoma. Clin Oncol. 2017;2:1308.
Carvalho CB, Capuzzo R, Crovador C, et al. Near infrared (NIR) fluorescence is not a substitute for lymphoscintigraphy and gamma probe for melanoma sentinel node detection: results from a prospective trial. Ann Surg Oncol. 2020. https://doi.org/10.1245/s10434-020-08409-6.
Author information
Authors and Affiliations
Corresponding author
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Vazquez, V.L. ASO Author Reflections: Near Infrared (NIR) Fluorescence is Not a Substitute for Lymphoscintigraphy and Gamma Probe for Melanoma Sentinel Node Detection: Results from a Prospective Trial. Ann Surg Oncol 27, 2913–2914 (2020). https://doi.org/10.1245/s10434-020-08410-z
Received:
Published:
Issue Date:
DOI: https://doi.org/10.1245/s10434-020-08410-z